Thrombophilia in sickle cell disease: The red cell connection

Blood

Volumn 98, Issue 12, 2001, Pages 3228-3233

  Yamaja Setty, B N ^a,b   Koneti Rao, A ^a,b   Stuart, Marie J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; D DIMER; FIBRIN; PHOSPHATIDYLSERINE; PLASMIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ERYTHROCYTE COUNT; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN CELL; INFANT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; THROMBOPHILIA;

EID: 0035761409     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.12.3228     Document Type: Article

References (30)

1. Francis RB, Hebbel RP. Hemostasis. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Hemostasis in sickle cell disease: basic principles and clinical practice. New York, NY: Raven Press; 1994:299-310.
2. Stuart MJ, Setty BNY. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med. 2001;20:27-46.
3. Leslie J, Langler D, Serjeant GR, Serjeant BE, Desai P, Gordon YB. Coagulation changes during the steady state in homozygous sickle cell disease in Jamaica. Br J Haematol. 1975;30:159-166.
4. Devine DV, Kinney TR, Thomas PF, Rosse WF, Greenberg CS. Fragment D-Dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood. 1986;68:317-319.
5. Francis RB. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis. 1989;19:105-111.
6. Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost. 1994;71:169-172.
7. Liesner R, Mackie I, Cookson J, et al. Prothrombolic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion. Br J Haematol. 1998;103:1037-1044.
8. Westerman MP, Green D, Gilman-Sachs A, et al. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med. 1999;134:352-362.
9. Francis RB. Protein S deficiency in sickle cell anemia. J Lab Clin Med. 1988;111:571-576.
10. Wright JG, Malia R, Cooper P, Thomas P, Preston F, Serjeant GR. Protein C and S in homozygous sickle cell disease. Br J Haematol. 1997;98:627-631.
11. Hofstra TC, Karla VK, Meiselman HJ, Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate neutrophil respiratory burst. Blood. 1996;87:4440-4447.
12. Lard LR, Mul FPJ, Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leucocyte Biol. 1999;66:411-415.
13. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000;106:411-420.
14. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and plateleterythrocyte aggregates in patients with sickle cell disease. J Lab Clin Med. 1997;129:507-516.
15. Key NS, Shingaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91:4216-4223.
16. Solovey A, Yi Lin BS, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell disease. New Engl J Med. 1997;337:1584-1590.
17. Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest. 1998;101:1899-1904.
18. Chiu D, Lubin B, Roelofsen B, van Deenen LLM. Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry. Blood. 1981;58:398-402.
19. Franck PFH, Bevers EM, Lubin BH, et al. Uncoupling of the membrane skeleton from the lipid bilayer: the cause of accelerated phospholipid flipflop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest. 1985;75:183-190.
20. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells: a review. Blood. 1997;89:1121-1132.
21. Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65:319-332.
22. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
23. Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood. 1996;87:1179-1187.
24. Setty BNY, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidyiserine exposure and coagulation activation. Blood. 2000;96:1119-1124.
25. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin, Blood. 1999;95:1293-1300.
26. Solovey AA, Solovey AN, Harkness J, Hebbel RP. Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood. 2001;97:19371941.
27. Helley D, Girot R, Claude Guillin M, Bezeaud A. Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation. Br J Haematol. 1997;99:268-272.
28. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
29. Styles L, de Jong K, Vichinsky E, Lubin B, Adams R, Kuypers F. Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial doppler screening. Blood. 1997;90:604a.
30. Tomer A, Kasey S, Connor WE, Clark S, Harker LA, Eckman JR. Reduction of pain episodes and prothrombotic activity in sickle cell disease. Thromb Haemost. 2001;85:966-974.